Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27416015 | 0.97 | HTT (0.46) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL9386229 | 0.80 | LMNA (0.39) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL15052257 | 0.78 | HTT (0.43) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL6686855 | 0.78 | HTT (0.43) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL7078980 | 0.78 | HTT (0.43) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL8370301 | 0.78 | HTT (0.59) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL7029367 | 0.75 | TSHR (0.44) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL10935344 | 0.75 | HTT (0.70) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL28496199 | 0.75 | HTT (0.44) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL8016485 | 0.74 | ALDH1A1 (0.42) | HTTMEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119215184-A | Pharmaceutical complex, pharmaceutical composition and use thereof | 聚天生医股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118852568-A | Efficient, green and universal fusion synthesis method for covalent organic frameworks | 浙江大学杭州国际科创中心 | 2024-10-29 | — | — | CN | claimed |
| CN-111212838-B | Deuterated Finanentane | 欧歌达有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-111212838-A | Deuterated Finanentane | 欧歌达有限公司 | 2020-05-29 | — | — | CN | claimed |
| JP-62056458-A | — | — | None | — | — | JP | disclosed |
| US-20260015655-A1 | COMPOUNDS AND THEIR APPLICATIONS | SFC CO., LTD. (KR) | 2026-01-15 | — | — | US | disclosed |
| EP-4674845-A1 | NOVEL COMPOUND AND USE THEREOF | SFC Co., Ltd. (KR) | 2026-01-07 | — | — | EP | disclosed |
| CN-119775198-A | Cancer therapy targeting cancer stem cells | 治疗方案股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-112566894-B | Potent inhibitors of D-amino acid oxidase (DAAO) and uses thereof | 心悦生医股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-119269811-A | Neuroactive steroids, compositions, and uses thereof | 萨奇治疗股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-119192267-A | Neuroactive steroids, compositions, and uses thereof | 萨奇治疗股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119192266-A | 3, 3-Disubstituted 19-norpregnane compounds, compositions, and uses thereof | 萨奇治疗股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| JP-S6256458-A | NOVEL AMINO ACID DERIVATIVE | KISSEI PHARMACEUT CO LTD | 1987-03-12 | — | — | JP | disclosed |
| EP-0151167-A4 | PHOSPHORAMIDE EPOXY RESINS. | DOW CHEMICAL CO (US) | 1986-01-07 | — | — | EP | disclosed |
| EP-0165439-A1 | Polyprenyl compound, process of producing it and pharmaceutical use | Eisai Co., Ltd. (JP) | 1985-12-27 | — | — | EP | disclosed |
| EP-0151167-A1 | PHOSPHORAMIDE EPOXY RESINS. | DOW CHEMICAL CO (US) | 1985-08-14 | — | — | EP | disclosed |
| WO-1985000611-A1 | PHOSPHORAMIDE EPOXY RESINS | THE DOW CHEMICAL COMPANY (US) | 1985-02-14 | — | — | WO | disclosed |
| US-4481347-A | ADDUCTS CURABLE TO POLYEPOXIDES | THE DOW CHEMICAL COMPANY (US) | 1984-11-06 | — | — | US | disclosed |
| US-4474943-A | Phosphoramide epoxy resins | THE DOW CHEMICAL COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
| US-3980644-A | EXTRACTION WITH CYCLOHEXANONE | ELI LILLY AND COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015655-A1 | COMPOUNDS AND THEIR APPLICATIONS | OGA, NSUN3, CDK10 | HTT 1836/4885MEN1 2365/4885KMT2A 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.